|
|
|
Insider
Information: |
Coughlin Christopher J |
Relationship: |
|
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
11 |
|
Direct
Shares |
342,599 |
|
Indirect Shares
|
17,342 |
|
|
Direct
Value |
$12,307,323 |
|
|
Indirect Value
|
$3,201,457 |
|
|
Total
Shares |
359,941 |
|
|
Total
Value |
$15,508,780 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-5.9%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Interpublic Group of Companies |
IPG |
CFO and COO, Director |
2004-05-18 |
81,842 |
2004-05-18 |
0 |
Premium* |
|
Dun & Bradstreet Corp |
DNB |
Director |
2017-03-10 |
16,535 |
2017-03-10 |
800 |
Premium* |
|
Johnson Controls International plc |
JCI |
EVP and CFO |
2010-11-26 |
88,558 |
2005-03-07 |
0 |
Premium* |
|
Covidien Plc |
COV |
Director |
2015-01-26 |
0 |
2015-01-26 |
0 |
Premium* |
|
Plx Pharma Inc |
PLXP |
Director |
2014-03-18 |
109,309 |
|
0 |
Premium* |
|
Allergan plc |
AGN |
Director |
2020-05-08 |
0 |
2020-05-08 |
16,542 |
Premium* |
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2021-07-21 |
0 |
2014-07-22 |
0 |
Premium* |
|
Hologic Inc |
HOLX |
Director |
2017-03-08 |
7,633 |
|
0 |
Premium* |
|
Prestige Brands Holdings Inc |
PBH |
Director |
2022-08-02 |
13,218 |
2019-07-30 |
0 |
Premium* |
|
Centene Corp |
CNC |
Director |
2024-05-14 |
25,504 |
2022-02-07 |
0 |
Premium* |
|
Karuna Therapeutics, Inc. |
KRTX |
|
2024-03-18 |
0 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
180 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DNB |
Dun & Bradstreet Corp |
Director |
|
2011-09-15 |
4 |
A |
$65.35 |
$3,126 |
D/D |
48 |
9,176 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2011-12-13 |
4 |
A |
$71.42 |
$3,143 |
D/D |
44 |
9,220 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2012-02-13 |
4 |
A |
$79.11 |
$120,002 |
D/D |
1,517 |
10,737 |
0 |
- |
|
COV |
Covidien Plc |
Director |
|
2012-05-07 |
4 |
A |
$54.25 |
$597 |
D/D |
11 |
46,097 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2012-06-13 |
4 |
A |
$67.32 |
$3,928 |
D/D |
58 |
10,841 |
0 |
- |
|
COV |
Covidien Plc |
Director |
|
2012-08-16 |
4 |
A |
$57.59 |
$576 |
D/D |
10 |
46,107 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2012-09-18 |
4 |
A |
$83.39 |
$3,950 |
D/D |
47 |
10,888 |
0 |
- |
|
COV |
Covidien Plc |
Director |
|
2012-11-05 |
4 |
A |
$55.65 |
$723 |
D/D |
13 |
46,120 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2012-12-13 |
4 |
A |
$80.90 |
$3,968 |
D/D |
49 |
10,937 |
0 |
- |
|
COV |
Covidien Plc |
Director |
|
2012-12-27 |
4 |
A |
$57.35 |
$688 |
D/D |
12 |
46,132 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2013-02-19 |
4 |
A |
$82.56 |
$119,952 |
D/D |
1,453 |
12,390 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2013-03-14 |
4 |
A |
$81.23 |
$4,778 |
D/D |
59 |
12,449 |
0 |
- |
|
COV |
Covidien Plc |
Director |
|
2013-05-03 |
4 |
A |
$64.35 |
$515 |
D/D |
8 |
47,302 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2013-06-13 |
4 |
A |
$98.79 |
$4,802 |
D/D |
49 |
12,497 |
0 |
- |
|
COV |
Covidien Plc |
Director |
|
2013-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
248 |
47,762 |
0 |
- |
|
COV |
Covidien Plc |
Director |
|
2013-08-15 |
4 |
A |
$61.85 |
$680 |
D/D |
11 |
47,773 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2013-09-18 |
4 |
A |
$106.96 |
$4,821 |
D/D |
45 |
12,543 |
0 |
- |
|
COV |
Covidien Plc |
Director |
|
2013-11-05 |
4 |
A |
$64.33 |
$836 |
D/D |
13 |
47,786 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2013-12-13 |
4 |
A |
$116.06 |
$4,839 |
D/D |
42 |
12,584 |
0 |
- |
|
COV |
Covidien Plc |
Director |
|
2014-02-20 |
4 |
A |
$71.28 |
$855 |
D/D |
12 |
47,798 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2014-03-12 |
4 |
A |
$98.08 |
$5,341 |
D/D |
54 |
12,639 |
0 |
- |
|
COV |
Covidien Plc |
Director |
|
2014-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
2,264 |
50,062 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2014-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,141 |
13,780 |
0 |
- |
|
COV |
Covidien Plc |
Director |
|
2014-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
420 |
49,446 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2014-06-13 |
4 |
A |
$103.94 |
$5,891 |
D/D |
57 |
13,836 |
0 |
- |
|
180 Records found
|
|
Page 3 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|